Skip to NavigationSkip to content

News

A team of scientists at the Institute of Cancer Research in London and the University of Edinburgh have developed an artificial intelligence that...
The EMA has awarded Britain’s regulatory body the MHRA just two contracts this year, as the European agency suggested that the uncertainty...
Novartis expands operations after Kymriah's EU approval, UK Government fails to reassure with "no deal" Brexit guidance, and homepathic medicines...
The global orphan and rare dermatology premium products market is expected to grow rapidly in the next half a decade according to the business...
Shire has completed the sale of its oncology franchise to French firm Servier for $2.4 billion, handing over the global and regional rights to a...
The Trump administration is in the process of drafting an alternative to the World Health Organization’s guidelines on the use of antimicrobial...
AstraZeneca has released a statement admitting that anifrolumab failed to meet its primary endpoint in a Phase 3 trial investigating its efficacy...
The company behind Natural Cycles, the first-ever approved smartphone app promising a natural alternative to contraception, has seen a Facebook...
The multiple sclerosis drug ibudilast, slowed brain shrinkages in patients with progressive MS, a study published in the New England Journal of...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches